ArticleCancer genomics & proteomics

HIF-1α and mTOR - Possible Novel Strategies of Targeted Therapies in p16-positive and -negative HNSCC.

Benedikt Kramer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.